PMID- 19141588 OWN - NLM STAT- MEDLINE DCOM- 20090514 LR - 20221207 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 94 IP - 4 DP - 2009 Apr TI - Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. PG - 1372-8 LID - 10.1210/jc.2008-1475 [doi] AB - AIM: Skeletal muscle mitochondrial content is reduced in type 2 diabetes mellitus (T2DM). Whether hyperglycemia inhibits mitochondrial biogenesis and/or function is unknown. This study examined the effect of different levels of glycemia on skeletal muscle mitochondrial function in patients with T2DM. PATIENTS AND METHODS: Eleven patients with T2DM [9 males, 2 females; age, 52.8 +/- 2.5 yr (mean +/- se); body mass index, 30.2 +/- 1.1 kg/m(2)] in poor glycemic control were treated with insulin aspart and NPH insulin for a median period of 46 d (range, 31-59). Mitochondrial respiration and citrate synthase activity (a marker of mitochondrial content) were measured before and after treatment. Eleven healthy subjects (age, 53.3 +/- 2.7 yr; body mass index, 30.6 +/- 1.1 kg/m(2)) were included as controls. RESULTS: Hemoglobin A1c (9.1 +/- 0.5 to 7.5 +/- 0.3%; P < 0.001) and fasting plasma glucose (12.7 +/- 1.1 to 6.5 +/- 0.3 mmol/liter; P < 0.001) were reduced after treatment. Mitochondrial respiration per milligram muscle was lower in T2DM compared to controls [substrates for complex I, 24% lower (P < 0.05); substrates for complex I+II, 17% lower (P < 0.05)]. Mitochondrial respiration and citrate synthase activity did not differ before and after improvements in glycemic control, but mitochondrial respiration correlated with fasting plasma glucose before (r(2) = 0.53; P < 0.05) but not after treatment [r(2) = 0.0024; not significant (NS)]. Mitochondrial respiration normalized to mitochondrial content did not differ between control subjects and patients with T2DM. DISCUSSION: Mitochondrial respiration and content was not improved after significant improvements in glycemic control. However, severe hyperglycemia inhibited respiration reversibly, but moderate hyperglycemia and mitochondrial function were not correlated. FAU - Rabol, Rasmus AU - Rabol R AD - Department of Biomedical Sciences, Faculty of Health Sciences, Copenhagen Muscle Research Centre, University of Copenhagen, Copenhagen, Denmark. rasmus.rabol@yale.edu FAU - Hojberg, Patricia M V AU - Hojberg PM FAU - Almdal, Thomas AU - Almdal T FAU - Boushel, Robert AU - Boushel R FAU - Haugaard, Steen B AU - Haugaard SB FAU - Madsbad, Sten AU - Madsbad S FAU - Dela, Flemming AU - Dela F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090113 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) RN - 4429-04-3 (Fructosamine) RN - 53027-39-7 (Insulin, Isophane) RN - D933668QVX (Insulin Aspart) SB - IM MH - Adult MH - Aged MH - Blood Glucose/drug effects/metabolism MH - Body Mass Index MH - Diabetes Mellitus, Type 2/blood/drug therapy/*metabolism MH - Female MH - Fructosamine/blood MH - Glycated Hemoglobin/drug effects/metabolism MH - Humans MH - Hyperglycemia/drug therapy/*metabolism MH - Hypoglycemic Agents/therapeutic use MH - Insulin/analogs & derivatives/therapeutic use MH - Insulin Aspart MH - Insulin, Isophane/therapeutic use MH - Male MH - Middle Aged MH - Mitochondria, Muscle/*metabolism MH - Muscle, Skeletal/metabolism MH - Oxygen Consumption/drug effects/*physiology EDAT- 2009/01/15 09:00 MHDA- 2009/05/15 09:00 CRDT- 2009/01/15 09:00 PHST- 2009/01/15 09:00 [entrez] PHST- 2009/01/15 09:00 [pubmed] PHST- 2009/05/15 09:00 [medline] AID - jc.2008-1475 [pii] AID - 10.1210/jc.2008-1475 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2009 Apr;94(4):1372-8. doi: 10.1210/jc.2008-1475. Epub 2009 Jan 13.